Companies › HTFL

HEARTFLOW INC (HTFL)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001464521 · EDGAR filings · Updated 2026-07-28

HEARTFLOW INC (HTFL) has reported institutional ownership of 75.4%, with 169 institutional managers holding positions valued at $1.59B per the latest 13F reporting period.

Filings this week (5)

• 2026-07-28 — Insider transaction reported (Form 4)
• 2026-07-28 — Insider transaction reported (Form 4)
• 2026-07-28 — SCHEDULE 13G filed
• 2026-07-24 — Insider transaction reported (Form 4)
• 2026-07-23 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-20 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, HEARTFLOW INC has 169 institutional holders and institutional ownership of 75.4%.

Insider activity

Insiders reported 50 transactions (1 buys, 8 sells) across 13 reporting insiders, with a net reported value of −$59.9M.

Related companies

VERADERMICS INC (MANE) · ARTIVION INC (AORT) · TREVI THERAPEUTICS INC (TRVI) · AMYLYX PHARMACEUTICALS INC (AMLX) · IMMUNOCORE HLDGS PLC (IMCR) · MBX BIOSCIENCES INC (MBX)